Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS): Interest of skin tests in cross-reactivity to phenobarbital - 04/07/23
Doi : 10.1016/j.therap.2023.06.005
Jawhar Rebai a, ⁎ 
, Haifa Ben Romdhane a, Khadija Mansour a, Najah Ben Fadhel a, Ines Lahouel b, Zohra Chadly a, Amel Chaabane a, Nadia Ben Fredj a, Karim Aouam a
, Haifa Ben Romdhane a, Khadija Mansour a, Najah Ben Fadhel a, Ines Lahouel b, Zohra Chadly a, Amel Chaabane a, Nadia Ben Fredj a, Karim Aouam a a Department of Pharmacology, Faculty de Medicine of Monastir, rue Avicenne, 5019 Monastir, Tunisia
b Dermatology Department, Fattouma Bourguiba Hospital, University of Medicine, 5019 Monastir, Tunisia
*Corresponding author.
In corso di stampa. Prove corrette dall'autore.
Disponibile online dal Tuesday 04 July 2023
Keywords : Drug reaction with eosinophilia and systemic symptoms, DRESS, Skin tests, Carbamazepine, Phenobarbital, Cross-reactivity
Abbreviations : ALT, AST, CBZ, CMV, DRESS, EBV, PCR, PHB, PHT
Il testo completo di questo articolo è disponibile in PDF.
Mappa
| ☆ | The 1st case was declared on February 17, 2022 under the number 199/22 and the 2nd case was declared on August 15, 2022 under the number 378/22 on Pharmacology Department of the Fattouma Bourguiba Hospital in Monastir (Tunisia). |
© 2023
Société française de pharmacologie et de thérapeutique. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?